XML 110 R98.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting - Revenue from Segments to Consolidated (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Segment Reporting, Revenue Reconciling Item [Line Items]    
Revenues [1] $ 297,057 $ 215,071
Adjusted EBITDA 24,255 14,907
Evolent Health Services    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Revenues 106,858 84,838
Clinical Solutions    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Revenues 190,199 130,233
Intersegment Eliminations    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Revenues (460) (438)
Operating Segments    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Revenues 297,057 215,071
Adjusted EBITDA 30,413 21,918
Operating Segments | Evolent Health Services    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Revenues 107,318 85,286
Adjusted EBITDA 8,217 5,942
Operating Segments | Clinical Solutions    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Revenues 190,199 130,223
Adjusted EBITDA 22,196 15,976
Corporate    
Segment Reporting, Revenue Reconciling Item [Line Items]    
Revenues 0 0
Adjusted EBITDA $ (6,158) $ (7,011)
[1] See Note 18 for amounts attributable to unconsolidated related parties included in these line items.